Registration for a live webinar on 'Precision medicine treatment for anticancer drug resistance' is now open.
See webinar detailsWe noted you are experiencing viewing problems
-
Check with your IT department that JWPlatform, JWPlayer and Amazon AWS & CloudFront are not being blocked by your network. The relevant domains are *.jwplatform.com, *.jwpsrv.com, *.jwpcdn.com, jwpltx.com, jwpsrv.a.ssl.fastly.net, *.amazonaws.com and *.cloudfront.net. The relevant ports are 80 and 443.
-
Check the following talk links to see which ones work correctly:
Auto Mode
HTTP Progressive Download Send us your results from the above test links at access@hstalks.com and we will contact you with further advice on troubleshooting your viewing problems. -
No luck yet? More tips for troubleshooting viewing issues
-
Contact HST Support access@hstalks.com
-
Please review our troubleshooting guide for tips and advice on resolving your viewing problems.
-
For additional help, please don't hesitate to contact HST support access@hstalks.com
We hope you have enjoyed this limited-length demo
This is a limited length demo talk; you may
login or
review methods of
obtaining more access.
Printable Handouts
Navigable Slide Index
- Introduction
- Core hematology parameters
- Minimizing variability
- Physiological / procedural variability
- Effect of strain
- Effect of excitement / fear
- Effect of restraint stress on leukocytes (rats)
- Effect of collection time on leukocyte counts
- Effect of collection site (mice)
- Artifact
- Other contributors to variability
- Appropriate use of reference intervals
- Some good study design practices
- Purpose of hematology tests
- Predictability for human hematotoxicity >/= 90%
- Classification of hematologic effects
- RBC parameters
- Control of erythropoiesis
- Instruments with animal-specific applications
- Hemoglobin concentration
- Red cell counting and sizing (RBC, MCV)
- Red cell counting and sizing (HCT, RDW)
- RBC vs. MCV: inverse relationship
- Calculated red cell indices & reticulocyte counting
- RBC and reticulocyte analysis
- Characteristics of young red cells
- Correlation of RBC data
- Increased red cell mass (HGB, HCT, RBC)
- Decreased red cell mass (HGB, HCT, RBC)
- Absolute decreased red cell mass
- Red cell loss (hemorrhage)
- Red cell destruction (hemolysis)
- Red cell loss or destruction
- Differences in RBC lifespan affect responses (1)
- Extramedullary hematopoiesis
- Decreased red cell production: causes
- Decreased red cell production: characteristics
- Differences in RBC lifespan affect responses (2)
- Anemia of chronic disease (1)
- Anemia of chronic disease (2)
- WBC parameters
- Counting and classifying leukocytes
- Advia
- Total WBC counts
- Species differences: lymphocyte/neutrophil ratio
- Leukocyte kinetics in health
- Increased leukocytes
- Decreased leukocytes
- Platelet parameters
- Platelets - overview
- Platelet counting and sizing
- Increased platelets
- Changes in platelet size
- Decreased platelets
- Hematopoiesis
- Bone marrow evaluation
- Summary
- Acknowledgements
- Abbreviations
Topics Covered
- Minimizing effects of preanalytical variables on hematology tests
- Proper use of reference intervals
- Evaluating rbc parameters
- Evaluating leukocyte parameters
- Evaluating platelet parameters
- Preparation and evaluation of bone marrow smears
Links
Series:
Categories:
Therapeutic Areas:
Talk Citation
Everds, N. (2009, August 26). Hematology interpretation for toxicity studies [Video file]. In The Biomedical & Life Sciences Collection, Henry Stewart Talks. Retrieved December 21, 2024, from https://doi.org/10.69645/BKSN9582.Export Citation (RIS)
Publication History
Financial Disclosures
- Dr. Nancy Everds has not informed HSTalks of any commercial/financial relationship that it is appropriate to disclose.
A selection of talks on Pharmaceutical Sciences
Transcript
Please wait while the transcript is being prepared...
0:00
Hello. My name is
Nancy Everds and I'm
a veterinary
clinical pathologist
at Amgen in Seattle Washington.
Today I'm going to talk
about the interpretation of
hematologic parameters
for toxicity studies.
0:14
Before we get very
far into this talk,
I want to go over what
the core hematology
parameters are.
These are generally included
in what we call the
complete blood count.
That includes red blood
cell mass parameters which
are red blood cell count
hemoglobin and hematocrit.
The red blood cell
indices which are
mean cell volume,
mean cell hemoglobin,
mean cell hemoglobin
concentration
and red cell distribution width.
The absolute
reticulocyte count which
is done on almost
every toxicity study.
The white blood cell count and
absolute differential white
blood cell counts and
two platelet parameters
usually the platelet count
and the mean platelet volume.
It's also important
to go ahead and
prepare a blood smear
even though you may not
need it to generate
the above parameters
because if you don't make
it at the time of analysis,
you can't go back
and make that smear.
It's really important to
always prepare a blood smear.
1:09
One of the most important
aspects of conducting
hematology tests on
toxicity studies
is the minimization
of variability.
It's really critical to
being able to generate
interpretable results.
Some of the potential sources of
variability include
physiologic effects,
procedural effects,
analytical effects,
artifacts either during
collection or analysis and
just basic study
design procedures
that impact the clinical
pathology result.